| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,359 | 1,171 | 742 | 366 | | Cost of Revenue | 708 | 1,872 |
-
| 2,080 | | | Gross Profit | 651 | (701) | 742 | (1,714) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,607 | 446 | 3,131 | 2,265 | | Non Recurring | 5,886 |
-
|
-
| 4,913 | | Others | 433 | 436 | 396 | 366 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,275) | (1,584) | (2,785) | (9,258) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 24 | (46) | 147 | 89 | | Earnings Before Interest And Taxes | (7,251) | (1,629) | (2,638) | (9,169) | | Interest Expense | 693 | 610 | 297 | 264 | | Income Before Tax | (7,944) | (2,239) | (2,935) | (9,433) | | Income Tax Expense | 6 | 23 |
-
| 26 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,950) | (2,262) | (2,935) | (9,459) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,950) | (2,262) | (2,935) | (9,459) | | Preferred Stock And Other Adjustments | (334) | (334) | (334) | (334) | | | Net Income Applicable To Common Shares | ($8,284) | ($2,596) | ($3,268) | ($9,793) |
|
0.51% Nasdaq 
0.0016 (0.75%) 
Income Statement
